AC2993 Program Update
Phase 3 AMIGO pivotal trials enrolled
- First study targeted to complete in 1H 2003
Initial open-label data reported in December 2002
- Mean reductions in HbA1c of 1.5% at 12 weeks
- No increase in mean body weight
NDA submission targeted for 2004